Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNITM, at the SCALE Symposium

AI Briefing

• – Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, at the SCALE Symposium.
• – Corabotase is being evaluated in Phase II for aesthetic glabellar lines indication.
• – Corabotase is recognized as the first in a newly designated class of molecules.